SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-185194
Filing Date
2014-05-06
Accepted
2014-05-06 17:29:40
Documents
6
Period of Report
2014-04-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d722531d8k.htm 8-K 18436
2 EX-10.1 d722531dex101.htm EX-10.1 64385
3 EX-10.2 d722531dex102.htm EX-10.2 16317
4 EX-10.3 d722531dex103.htm EX-10.3 82959
5 EX-10.4 d722531dex104.htm EX-10.4 65904
6 EX-10.5 d722531dex105.htm EX-10.5 53064
  Complete submission text file 0001193125-14-185194.txt   302437
Mailing Address 7180 SW SANDBURG STREET, SUITE 100 TIGARD OR 97223
Business Address 7180 SW SANDBURG STREET, SUITE 100 TIGARD OR 97223 503-692-8001
BIOJECT MEDICAL TECHNOLOGIES INC (Filer) CIK: 0000810084 (see all company filings)

IRS No.: 931099680 | State of Incorp.: OR | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15360 | Film No.: 14818236
SIC: 3841 Surgical & Medical Instruments & Apparatus